Management of multiple myeloma complicated by hepatitis C virus reactivation: The role of new antiviral therapy

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Mahale, Parag ^a   Thomas, Sheeba K ^b   Kyvernitakis, Andreas ^a   Torres, Harrys A ^a  

^a and Employee Health

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hepatitis C virus; Multiple myeloma; Thalidomide; Viral reactivation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DEXAMETHASONE; MELPHALAN; PARAPROTEIN; RIBAVIRIN; SOFOSBUVIR; THALIDOMIDE; VIRUS RNA;

AGED; ANTIVIRAL THERAPY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CASE REPORT; CHRONIC HEPATITIS C; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 2; HUMAN; LYMPHOCYTE COUNT; MULTIPLE MYELOMA; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS REACTIVATION;

EID: 85000444141     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv211     Document Type: Article

References (13)

1. Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 2012; 57: 1177-85.
2. Bhandari MS, Mazumder A, Vesole DH. Liver involvement in multiple myeloma. Clin Lymphoma Myeloma 2007; 7:538-40.
3. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015; 62:932-54.
4. Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther 2003; 25:342-95.
5. Corral LG, Kaplan G. Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis 1999; 58(Suppl 1):I107-13.
6. Grigg AP, Sasadeusz J. Hepatitis B reactivation after thalidomide. Intern Med J 2008; 38:301-2.
7. Fowler R, Imrie K. Thalidomide-associated hepatitis: a case report. Am J Hematol 2001; 66:300-2.
8. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 2012; 9:156-66.
9. Henry SD, Metselaar HJ, Van Dijck J, et al. Impact of steroids on hepatitis C virus replication in vivo and in vitro. Ann N Y Acad Sci 2007; 1110:439-47.
10. Rance E, Tanner JE, Alfieri C. Inhibition of IkappaB kinase by thalidomide increases hepatitis C virus RNA replication. J Viral Hepat 2012; 19:e73-80.
11. Torres HA, Chong PP, De Lima M, et al. Hepatitis C virus infection among hematopoietic cell transplant donors and recipients: American Society for Blood and Marrow Transplantation Task Force recommendations. Biol Blood Marrow Transplant 2015; 21:1870-82.
12. Kyvernitakis A, Mahale P, Popat UR, et al. Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents. Biol Blood Marrow Transplant 2015; doi:10.1016/j.bbmt.2015. 12.010.
13. Mahale P, Kyvernitakis A, Kantarjian H, et al. Concomitant use of chemotherapy and antivirals in hepatitis C virus infected cancer patients. Hepatology 2015; 62:114A: Abstract 1160.